title: Surrogate endpoints: can size of effect mitigate perplexity?
authors.affiliation: Clinical Trials Unit, National Cancer Institute of Naples, Naples, Italy. f.perrone@istitutotumori.na.it
authors.forename: Francesco
authors.initials: F
authors.lastname: Perrone
mesh_terms: D015415:Biomarkers; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality*; D059248:Chemoradiotherapy / Q000401:mortality*; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality*
chemical_list: D015415:Biomarkers